Literature DB >> 24648209

MicroRNAs in the bile of patients with biliary strictures after liver transplantation.

Tim O Lankisch1, Torsten Voigtländer, Michael P Manns, Angelika Holzmann, Seema Dangwal, Thomas Thum.   

Abstract

Biliary complications after liver transplantation remain a major cause of morbidity and reduced graft survival. Ischemic-type biliary lesions (ITBLs) are common and difficult to treat. The pathophysiology of ITBLs remains unclear, and diagnostic markers are still missing. The analysis of microRNA (miRNA) profiles is an evolving field in hepatology. Our aim was to identify specific miRNA patterns in the bile of patients with ITBLs after liver transplantation. Liver transplant patients with biliary complications were included in a cross-sectional study. Patients with ITBLs (n = 37), anastomotic strictures (ASs; n = 39), and bile duct stones (BDSs; n = 12) were compared. Patients with ITBLs were categorized by disease severity. The miRNA concentrations in bile were determined with global miRNA profiling and subsequent miRNA-specific polymerase chain reaction-mediated validation. The concentrations of microRNA 517a (miR-517a), miR-892a, and miR-106a* in bile were increased for patients with ITBLs versus patients with ASs or BDSs (P < 0.05). Categorization by ITBL severity showed higher median concentrations in patients with intrahepatic and extrahepatic strictures (P > 0.05). miR-210, miR-337-5p, miR-577, and miR-329 displayed no statistical differences. In conclusion, miR-517a, miR-892a, and miR-106a* are increased in the bile fluid of patients with ITBLs versus patients with ASs or BDSs. An analysis of miRNA profiles may be useful in the diagnosis and management of patients with ITBLs. Future studies are needed to prove the potential prognostic value of these miRNAs.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24648209     DOI: 10.1002/lt.23872

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

1.  miRNA-24 and miRNA-466i-5p controls inflammation in rat hepatocytes.

Authors:  Subramanian Saravanan; Krishnaraj Thirugnanasambantham; Hamza Hanieh; Kulandaivelu Karikalan; Durairaj Sekar; Rukkumani Rajagopalan; Villianur Ibrahim Hairul Islam
Journal:  Cell Mol Immunol       Date:  2014-09-08       Impact factor: 11.530

2.  MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.

Authors:  Torsten Voigtländer; Shashi K Gupta; Sabrina Thum; Jasmin Fendrich; Michael P Manns; Tim O Lankisch; Thomas Thum
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

3.  Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.

Authors:  Jarkko Soronen; Hannele Yki-Järvinen; You Zhou; Sanja Sädevirta; Antti-Pekka Sarin; Marja Leivonen; Ksenia Sevastianova; Julia Perttilä; Pirkka-Pekka Laurila; Alexander Sigruener; Gerd Schmitz; Vesa M Olkkonen
Journal:  Physiol Rep       Date:  2016-01

Review 4.  Review: Ischemia Reperfusion Injury-A Translational Perspective in Organ Transplantation.

Authors:  André Renaldo Fernández; Rodrigo Sánchez-Tarjuelo; Paolo Cravedi; Jordi Ochando; Marcos López-Hoyos
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

5.  Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids.

Authors:  Henk P Roest; Jan N M IJzermans; Luc J W van der Laan
Journal:  BMC Biotechnol       Date:  2021-08-06       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.